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Pyrazoline is a five member heterocyclic ring which is a versatile lead compound for designing potent 
bioactive agents. The review of the literature shows that the pyrazoline derivatives are quite stable and has 
inspired the chemists to synthesize the new pyrazoline derivatives. The past studies of pyrazoline derivative 
revealed that they are useful in pharmaceutical and agrochemical research. Pyrazoline derivatives display 
various pharmacological activities such as antitumor, antitubercular, antimicrobial, antibacterial, anti-
inflammatory and antioxidant etc. and the pharmacological activities of different synthesized compound are 
reviewed in the present article. 
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INTRODUCTION 
Pyrazoles are five member ring heterocyclic 
compounds, have some structural features with two 
nitrogen atoms in adjacent position and are also called 
as Azoles [1]. It has only one endocyclic double bond 
and is basic in nature. The best described property of 
almost every group of pyrazoles is in the treatment of 
inflammation and inflammation associated disorders, 
such as arthritis [2]. Pyrazole derivatives are the 
subject of many research studies due to their 
widespread potential biological activities such as 
antimicrobial [3], antiviral [4], antitumor [5, 6], 
antihistaminic [7], antidepressant [8], anti-
inflammatory [9], tranquillizing [10], anticancer [11, 
12], anti-hypertensive [13], anti-arrhythmic [14], 
psychoanaleptic [15], anticonvulsant [16] & anti-
diabetic activities [17]. Mostly pyarazolone are 
synthesized taking ethylacetoacetate and substituted 
hydrazine as starting chemicals. Pyrazolone was first 
prepared by Knorr in1883 when he was trying to 
synthesis quinoline derivatives, but he obtained 
pyrazolone derivative called antipyrin , and also called 
phenazone .Pyrazolone can be considered as 
intermediate compound for synthesis of various cyclic 
compounds of high biological activity.  
Pyrazoline is basic in nature. An intra molecular 
conjugated charge transfer process has been reported to 
exist in it in the excited state.  
The conjugated part (–N1–N2–C3–) of the ring, the 
nitrogen atom at the 1-position and the carbon atom at 
the 3-position are, respectively, electron donating and 
withdrawing moieties. The carbon atoms at 4- and 5-
positions do not conjugate with the remaining part of 
the ring. In general pyrazolones are yellow solids with 
high melting points and moderate solubility in water, 
alkaline and acidic solutions. They react with 
aldehydes in alcoholic basic medium and with the 
bromine to give high biologically active compounds. It 
is reported that pyrazolones undergo tautomerism to 
certain extent which are affected by substituent and 
solvents. 
 
 
Pharmacological Activities 
[A] Antibacterial activity 
Mogilaiah et al [18] synthesized & found antibacterial 
activities of 1, 3, 4-Oxadiazole and pyrazoline 
derivatives containing 1, 8-Naphthyridine moiety. All 
the compounds were far less active than the standard 
drug (gentamycin) taken. 
 
Vergiya et al [19] synthesized some new 3, 5-Diaryl-1-
phenyl/isonicotinoyl-2-pyrazolines and evaluated its 
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biological activity. All the synthesized compounds 
showed antibacterial activity against Gram +ve bacteria 
S. Aureus, S.albus, S. pyogenes, S. Viridians and Gram 
-ve bacteria E. coli, S. Typhosa 
 
Waheed et al [20] synthesized certain substituted 1, 2-
Pyrazolines from nalidixic acid as antibacterial and 
analgesic agents. They were found to have significant 
antibacterial activity against Gram –ve bacteria and 
possessed appreciable analgesic activity. 
 
Abdullah et al [21] Synthesized of new 3-(5-aryl-4,5-
dihydro-1H-pyrazol-3-yl)-4-hydroxy-2H- chromene-2-
one derivatives and evaluation of their antibacterial 
activity. 
 
 
[B] Antitubercular activity 
Kini et al [22] synthesized a novel series of 
heterocyclic o/m/psubstituteddiphenyl ether derivatives 
and determined their activity against H37Rv strain of 
Mycobacterium. All 10 compounds inhibited the 
growth at concentrations as low as 1 μg.ml-1. This 
level of activity was found comparable to the reference 
drugs rifampicin and isoniazid at the same 
concentration. 
 
Ali et al [23] synthesized a series of 5-(-4-(Substituted) 
phenyl)-3-(4-hydroxy-3-methylphenyl)-4,5-dihydro-
1H-1-pyrazolyl-2-toluidino methanethione and 5-
(Substituted)phenyl-3- (4-hydroxy-3-methylphenyl)- 4, 
5 – dihydro – 1H – 1 – pyrazolyl – 2 – methoxyanilino  
methanethione and tested for their in vitro 
antitubercular activity against M. tuberculosis H37Rv. 
Among the synthesized compounds, compound Anilino 
– 3 - (4 – hydroxyl – 3 – methylphenyl) – 5 - (2, 6-
dichloro phenyl)-4, 5-dihydro- 1H- 1-pyrazolyl 
methanethione was found to be more active agent 
against M. tuberculosis H37Rv with minimum 
inhibitory concentration of 0.0034μM. 
 
Babu et al [24] synthesized and evaluated biological 
activity of 1, 3, 5 – Trisubstituted pyrazolines bearing 
benzofuran. They were found to be antitubercular, 
antimicrobial and anti-inflammatory in nature. 
 
Joshi et al [25] Synthesized a series of 1-acetyl-3,5-
diphenyl-4,5-dihydro-(1H)-pyrazole derivatives and 
evaluation of their antitubercular activity. 
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[C] Antimicrobial activity 
Ozdemir et al [26] synthesized several 1-(4-Aryl-2-
thiazolyl)-3-(2-thienyl)-5-aryl-2-pyrazoline derivatives 
and investigated their antimicrobial activities against 
Escherichia coli, Staphylococcus aureus, Salmonella 
typhimurium, Bacillus cereus, Streptococcus faecalis, 
Aeromonas hydrophila, Candida albicans and Candida 
glabrata. A significant level of activity was observed. 
 
Abdelwahab et al [27] synthesized 1-(Benzofuran-2-
yl)-4-nitro-3-arylbutan-1-ones and 3(Benzofuran-2-yl)-
4,5-dihydro-5-aryl-1-[4-(aryl)-1,3-thiazol-2-yl]-1H-
pyrazolesand evaluated their antibacterial and 
antifungal activities at 100 μg concentration. Some of 
the compounds showed excellent antimicrobial 
activities than control drugs. 
 
Stirrett et al [28] synthesized small molecules with 
structural similarities to siderophores and evaluated as 
novel antimicrobials against Mycobacterium 
tuberculosis and Yersinia pestis. 
 
Agrawal et al [29] Synthesized of 1,3,5-trisubstituted 
pyrazoline derivatives and screening for their 
antimicrobial activity. 
 
 
Hassan [30] synthesized new pyrazoline derivatives 
and evaluated their anti microbial activity. 
 
 
[D]Anti-inflammatory activity 
Amir et al [31] synthesized a series of 3-(4-Biphenyl)-
5-substituted phenyl-2-pyrazolines and 1-Benzoyl-3-
(4-biphenyl)-5-substituted phenyl-2- pyrazolines and 
screened for their anti-inflammatory and analgesic 
activity. Among the compounds studied, compound-17 
showed more potent anti-inflammatory and analgesic 
activity than the standard drug, along with minimum 
ulcerogenic index. 
 
Barsoum et al [32] synthesized a variety of Bis(3 – aryl 
– 4, 5 – dihydro – 1H – pyrazole – 1 – carboxamides) 
and screened for their anti-inflammatory properties and 
PGE2 inhibitory properties (at a dose level of 50 
mg.kg-1) utilizing in vivo acute carrageenan – induced 
paw oedema standard method in rats. They exhibited 
that many of the tested compounds reveal considerable 
anti-inflammatory properties, especially which reveal 
remarkable activities related to indomethacin (which 
was used as a reference standard at a dose of 10 mg.kg-
1 of body weight). They exhibited lower ulcer index 
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values than the used reference standard (indomethacin).
 
 
Khalil [33] synthesized 1 – acetyl/propanoyl – 5 – aryl 
– 3 – (4 – morpholinophenyl) – 4, 5 – dihydro – 1H – 
pyrazole derivatives and evaluated their anti-
inflammatory activity. 
 
Mahesh et al [34] synthesized a new series of 3, 5-
diaryl-1-phenyl-2-pyrazoline by cyclocondensation of 
chalcones with phenyl hydrazine. The compounds were 
screened in vivo for their anti – inflammatory activity 
by using carrageenan induced rat paw edema method. 
Compounds P4, P7, P8 , P10 have shown maximum 
anti-inflammatory activity. 
 
[E] ANTITUMOR ACTIVITY 
Braulio et al [35] synthesized a series of novel 3- aryl-
4-(3- aryl -4, 5-dihydro-1H-pyrazol-5-yl)-1-phenyl -
1H-pyrazoles and 1-substituted 3-aryl-5-aryl (hetaryl)-
2-pyrazolines and screened their antitumor activity. 
 
Zhu et al [36] Synthesized a series of 3-(substituted 
phenyl) - 5-(substituted phenyl) - 4, 5-dihydro-1H-
pyrazole- 1-carbothioamide and 1-(5-(substituted 
phenyl)-3-(substituted phenyl)-4, 5-dihydro-1H-
pyrazol-1-yl) ethanone as anticancer agents. 
 
Havrylyuk et al [37] synthesized several novel 
thiazolone based compounds containing 5-Aryl-3-
phenyl-4, 5-dihydro-1Hpyrazol-1-yl framework and 
tested for in vitro anticancer activity. Most of them 
displayed anticancer activity on leukemia, melanoma, 
lung, colon, CNS, ovarian, renal, and prostate and 
breast cancer cell lines. The most efficient anticancer 
compound-39 was found to be active with selective 
influence on colon cancer cell lines, especially on HT 
29 (log GI50 = -6.37). 
 
[F] ANALGESIC ACTIVITY: 
Shau et al [38] synthesized a series of novel 4-(5-
substituted aryl-4, 5-dihydropyrazole-3-yl-amino) 
phenols 2a-f where introduction of p-nitro and 
phydroxy group in aryl moiety of the pyrazoleanalogs 
2c and 2e produce compounds with potent analgesic, 
anti-inflamatory and, in a few cases, antimicrobial 
properties. 
 
Sivakumar et al [39], synthesized a series of (4Z)-3-
methyl-1-[(2-oxo-2H-chromen-4-yl) carbonyl]-1H-
pyrazole- 4, 5- dione 4- [(4- substituted phenyl) 
hydrazone] (5a-i). The titled compounds were screened 
for their anti-inflammatory and analgesic activity. 
Among the synthesized compounds, compound 5a, 5c, 
5g and 5h exhibited significant anti-microbial activity 
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and compound 5a, 5b, 5d, 5h and 5i exhibited 
significant analgesic activity compared with the 
standard drug (indomethacin5mg/kg) at the dose level 
of 50mg/kg on oral administration. 
 
 
[G] ANTIFUNGAL ACTIVITY: 
Baseer  et al [40] synthesized fourteen new N-
acetylated and non-acetylated pyrazoline derivatives  
by  reacting chalcones with hydrazine in the presence 
of absolute ethanol however reaction was carried out in 
the presence of glacial acetic acid to afford N-
acetylated pyrazolines. The pyrazolines (1-14) were 
screened for antifungal activity against Aspergillus 
flavus, Aspergillus niger and Aspergillus pterus. 
Pyrazolines (1-14) found to exhibit well to excellent 
anti fungal properties 
 
Ramiz et al [41] synthesized a series of new pyrazolone 
and pyrazole derivatives with expected anti fungicidal 
activity through the reactions 3-phenyl-1-H-pyrazol-
5(4H)- one (3) and 4-(dimethyl amino methylene)-3-
phenyl-1H-pyrazol-5(4H)-one (5) with a variety of 
electrophilic reagents and nucleophilic reagents. 
 
[H] ANTICONVULSANT ACTIVITY: 
Singh et al [42] synthesized a series of 1-[(4,5-dihydro- 
5-phenyl-3-(phenyl amino) pyrazol-1yl)] ethanone 
derivatives I-VI were synthesized and evaluated for 
their anticonvulsant activity against electric shock 
induced convulsion method. Compounds III and V are 
found to be the most potent compounds of all 
synthesized compounds. 
 
Singh et al [43] synthesized several 3-(3-Acetoamino) 
phenyl-1, 5-substituted phenyl-2-pyrazolines [21] 
which were evaluated for their anticonvulsant activity. 
All the substituted pyrazolines exhibited anticonvulsant 
activity, which was reflected by 30-80% protection 
observed against PTZ-induced seizures. 
 
 
[I] ANTIHELMINTIC ACTIVITY: 
Sreenivasa et al [44] synthesized a series of pyrazole 
derivatives and evaluated for their anthelmentic 
activity. Synthesized compounds of pyrazole 
derivatives were tested for anthelmintic activity against 
earthworms, Peritumaposthuma compared to standard 
Albendazole. VII P8, VIII P6,VIII P7, VIII P8, VIII 
P9, VIII P10, VIII P11, VIII P12 showed significant 
activity compared to standard Albendazole. 
 
 
[J] ANTIOXIDANT ACTIVITY 
Pasin et al [45] synthesized a series of pyrazole 
derivatives and screened for their antioxidant activity. 
All compound showing good activity. 
 
Umesha et al [46] Synthesized of 5-methyl-2- (5-
methyl- 1,3-diphenyl-1H-pyrazole-4- carbonyl)-2, 4-
dihydro- pyrazol-3-one and evaluation of their 
antioxidant activity. 
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Babu et al [47] synthesized a series of pyrazoline 
derivatives and evaluated antioxidant activity at 1000, 
500, 250, 100, 50, 25 and 10 mg.ml-1 concentrations 
against standard drug ascorbic acid. Six of the 
synthesized compounds showed interesting antioxidant 
activity as compared with ascorbic acid. 
 
 
[K] CYTOTOXIC ACTIVITY 
Zahar et al [48] synthesized a series of pyrazole 
derivatives which show good activity 
.  
[L] HERBICIDAL 
Noriaki et al [49] synthesized a series of 1,5-
Diarylpyrazole Derivatives Some of these compounds 
showed noticeable pre-emergent herbicidal activities 
against various kinds of weeds. Among the synthesized 
compounds, methyl 4-chloro-1-(2,5-difluorophenyl)-5-
(4-flurophenyl)-pyrazole-3-carboxylate 19t exhibited 
good activity. Diarylimidazole carboxylates and 
carboxamides were also synthesized, but they did not 
show any herbicidal activities. 
 
 
[M] ACE INHIBITORY ACTIVITY 
Bonesi et al [50] synthesized a series of pyrazole 
derivatives and investigated their angiotensin I 
converting enzyme inhibitory activity by performing 
assay. The following pyrazole derivative-25 showed 
effective ACE-inhibitory activity with0.123m MIC 
value.       
 
 
[N] ANTIHYPERTENSIVE ACTIVITY 
Zitouni et al [51] synthesized some 1-(4-Arylthiazol-2-
yl)-3, 5-diaryl-2- pyrazoline derivatives and 
investigated their hypotensive activity by the tail-cut 
method using clonidine as reference compound. All 
examined compounds showed appreciable hypotensive 
activities. One of the active compounds is given below 
 
 
[O] CHOLESTEROL INHIBITORY ACTIVITY: 
Jeong et al [52] synthesized a series of 3-(3, 5-Di-tert-
butyl-4-hydroxyphenyl)-5-(multi-substituted 4-hydroxy 
phenyl)-2-pyrazolines and carried out their inhibitory 
activity on acyl-CoA: cholesterol acyltransferase.They 
showed invitroinhibitory activity on hACAT-1 and -2. 
One of the active compounds is shown below 
 
 
CONCLUSION: 
Pyrazolone moiety and its various derivatives was 
studied frequently in the past time and found potent in 
various pharmacological and pathological conditions, 
which are discussed in brief in this article.In 
conclusion,we have described thebiological activities 
of pyrazoline derivatives such as antitumor, 
antitubercular, antimicrobial, antibacterial, anti-
inflammatory and antioxidant etc.Various other 
activities are also been studied like anticonvulsant, 
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anticancer, antihelmintic etc. Thus by studying all the 
derivatives showing variety of activities we can say 
that pyrazole ring have been explored in past years and 
is still be used for future development of new drugs 
against many more pathological conditions. 
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